34 results
8-K
EX-10.1
ATHA
Athira Pharma Inc
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
: [Finance Department]
2.Exercise of Option. Effective as of today, ________________, ____, the undersigned (“Participant”) hereby elects to exercise
8-K
EX-10.3
7jd vy5z1rqsjyp93d
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
DFAN14A
EX-99.1
x7k83m1
25 Apr 22
Additional proxy materials by non-management
3:31pm
DFAN14A
EX-99.1
7b687bxkponr
13 Apr 22
Additional proxy materials by non-management
5:29pm
8-K
EX-99.1
rlm f71kd5ayf6o5k
24 Mar 22
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
4:11pm
8-K
EX-10.1
3jotnzjjz 2ak4eq6nkz
21 Oct 21
Departure of Directors or Certain Officers
4:09pm
DEF 14A
kh5987ib8
16 Apr 21
Definitive proxy
6:02am
10-K
xuc853 23c5xp
25 Mar 21
Annual report
12:00am